FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease

Inflammatory Bowel Diseases

Volumn 15, Issue 9, 2009, Pages 1351-1357

  Mendoza, Juan Luis ^a,b   Lana, Raquel ^a   Martin, Maria C ^a   De La Concha, Emilio G ^a   Urcelay, Elena ^a   Diaz Rubio, Manuel ^a   Abreu, Maria T ^b   Mitchell, Adele A ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; FcRL3; Inflammatory bowel disease; Peripheral arthritis; Peripheral arthropathy

Indexed keywords

FC RECEPTOR; FC RECEPTOR LIKE 3; UNCLASSIFIED DRUG; FCRL3 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTHRALGIA; ARTHROPATHY; ARTICLE; AUTOIMMUNE DISEASE; CROHN DISEASE; DISEASE CLASSIFICATION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SACROILIITIS; ARTHRITIS; CHILD; CLINICAL TRIAL; GENETICS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; CHILD; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; YOUNG ADULT;

EID: 70449725001     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20895     Document Type: Article

References (46)

1. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:307-327. (Pubitemid 34733048)
2. Mendoza JL, Lana R, Taxonera C, et al. [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis.] Med Clin (Barc). 2005;125:297-300.
3. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut. 2006;55(suppl 1):i36-58. (Pubitemid 43268292)
4. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55:401-412.
5. Wright V, Watkinson G. The arthritis of ulcerative colitis. Br Med J. 1965;2:670-675.
6. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology. 1975;68:627-635.
7. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42:387-391.
8. Kethu SR. Extraintestinal manifestations of inflammatory bowel diseases. J Clin Gastroenterol. 2006;40:467-475. (Pubitemid 44318130)
9. Barreiro-de Acosta M, Dominguez-Munoz JE, Nunez-Pardo de Vera MC, et al. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol. 2007;19:73-78.
10. Wagtmans MJ, Verspaget HW, Lamers CB, et al. Gender-related differences in the clinical course of Crohn's disease. Am J Gastroenterol. 2001;96:1541-1546. (Pubitemid 32455087)
11. Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9:2300-2307. (Pubitemid 37321464)
12. Nemetz A, Molnar T, Zagoni T, et al. Phenotypes defined by the "Vienna Classification" in 100 Hungarian patients with Crohn's disease. Rev Esp Enferm Dig. 2003;95:533-8, 27-33.
13. Orchard TR, Thiyagaraja S, Welsh KI, et al. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology. 2000;118:274-278. (Pubitemid 30067500)
14. Nunez C, Alecsandru DM, Mendoza JL, et al. Genetic markers linked to rheumatoid arthritis are also strongly associated with articular manifestations in ulcerative colitis patients. Hum Immunol. 2006;67:324-330. (Pubitemid 44250962)
15. Fischer S, Lakatos PL, Hungarian IBD Study Group, et al. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgery in Hungarian patients with inflammatory bowel diseases. Scand J Gastroenterol. 2007;42:726-733. (Pubitemid 46763580)
16. Chistiakov DA, Chistiakov AP. Is FCRL3 a new general autoimmunity gene? Hum Immunol. 2007;68:375-383.
17. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678.
18. Begovich AB, Chang M, Schrodi SJ. Meta-analysis evidence of a differential risk of the FCRL3 -169T->C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum. 2007;56:3168-3171. (Pubitemid 47502766)
19. Ikari K, Momohara S, Nakamura T, et al. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis. 2006;65:671-673.
20. Kochi Y, Yamada R, Suzuki A, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet. 2005;37:478-485. (Pubitemid 40617275)
21. Thabet MM, Wesoly J, Slagboom PE, et al. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis. 2007;66:803-806. (Pubitemid 46846701)
22. Eike MC, Nordang GB, Karlsen TH, et al. The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases. Ann Rheum Dis. 2008;67:1287-1291.
23. Davis RS, Wang YH, Kubagawa H, et al. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci U S A. 2001;98:9772-9777. (Pubitemid 32769379)
24. Shen N, Tsao BP. Current advances in the human lupus genetics. Curr Rheumatol Rep. 2004;6:391-398.
25. Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329-1337.
26. Giardina E, Sinibaldi C, Chini L, et al. Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21. Hum Hered. 2006;61:229-236. (Pubitemid 44357220)
27. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-19.
28. Gabriel S. Classification of rheumatic disease. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. London: Mosby; 2003:9-12.
29. Kimura A, Sasazuki T. Eleventh International Histocompatability workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press. 1991;397-419.
30. StataCorp. Stata statistical software: release 8.2. College Station, TX: StataCorp LP; 2004.
31. www.r-project.org Accessed 10 Jun 2008.
32. Scheet P, Stephens M. A fast and flexible statistical model for largescale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet. 2006;78:629-644.
33. Martinez A, Nunez C, Martin MC, et al. Epistatic interaction between FCRL3 and MHC in Spanish patients with IBD. Tissue Antigens. 2007;69:313-317. (Pubitemid 46481076)
34. Reinisch W, Miehsler W, Dejaco C, et al. An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia. Aliment Pharmacol Ther. 2003;17:1371-1380. (Pubitemid 36774144)
35. Palm O, Bernklev T, Moum B, et al. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol. 2005;32:1755-1759. (Pubitemid 41324817)
36. Sandborn WJ, Stenson WF, Brynskov J, et al. Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. Clin Gastroenterol Hepatol. 2006;4:203-211. (Pubitemid 43199691)
37. May E, Marker-Hermann E, Wittig BM, et al. Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology. 2000;119:1745-1755. (Pubitemid 32198700)
38. Mielants H, Veys EM, Cuvelier C, et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol. 1995;22:2273-2278.
39. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2:777-1280
40. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996;98:945-953.
41. Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun. 1999;67:2969-2974.
42. Rath HC, Ikeda JS, Linde HJ, et al. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology. 1999;116:310-319.
43. Orchard TR, Jewell DP. The importance of ileocecal integrity in the arthritic complications of Crohn's disease. Inflamm Bowel Dis. 1999;5:92-97.
44. Silverberg MS, Mirea L, Bull SB, et al. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:1-9. (Pubitemid 36124242)
45. Fernandez L, Mendoza JL, Martinez A, et al. IBD1 and IBD3 determine location of Crohn's disease in the Spanish population. Inflamm Bowel Dis. 2004;10:715-722. (Pubitemid 39545215)
46. Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. World J Gastroenterol. 2006;12:3628-3635. (Pubitemid 43950938)